Letters
Large pragmatic randomised studies of new antiepileptic drugs are needed
BMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7096.1764a (Published 14 June 1997) Cite this as: BMJ 1997;314:1764
- Anthony Marson, Lecturer in neurologya,
- Zakaria Kadir, Honorary senior registrara,
- David Chadwick, Professor of neurologya
- a Walton Centre for Neurology and Neurosurgery, University of Liverpool, Liverpool L9 1AE
Editor—Two letters commenting on our systematic review of trials of new antiepileptic drugs1 deserve a response. We agree with A J A Elferink and B J Van Zwieten-Boot that the number needed to treat is a useful statistic, but we believe that they are wrong to suggest that we should have presented it rather than odds ratios.2 We had in fact undertaken a risk difference analysis (1/number needed to treat) and found much greater heterogeneity with …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.